Back
CRISPR Therapeutics AG Stock Predictions
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
32
CRSP
CRISPR Therapeutics AG
Last Price:
56.15
Seasonality Move:
25.22%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeCRISPR Therapeutics AG Stock Forecast
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 37.1% based on the past 7 years of stock performance.
- CRISPR Therapeutics AG has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is CRISPR Therapeutics AG Stock Undervalued?
The current CRISPR Therapeutics AG [CRSP] share price is $55.56. The Score for CRSP is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 37.1% based on the past 7 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
32
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
- CRISPR Therapeutics AG has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
91.10
52-Week Low:
37.55
Prediction Charts
Market Cap:
4.72B
Price in USD:
55.56
Volume:
1.4M
Beta:
1.99
Technical Analysis
SMA50:
73.15
SMA100:
68.90
SMA200:
59.50
52-Wk Change:
2.34%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?
Yes, CRISPR Therapeutics AG is a publicly traded company. -
What is the CRISPR Therapeutics AG stock quote today?
The CRISPR Therapeutics AG stock price is 55.56 USD today. -
How to buy CRISPR Therapeutics AG stock online?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-28 | 69.98 | 68.16 | 70.12 | 67.52 |
| Apr-1 | 68.15 | 68.18 | 68.39 | 66.50 |
| Apr-2 | 66.00 | 64.97 | 66.39 | 64.26 |
| Apr-3 | 64.73 | 64.59 | 65.46 | 63.60 |
| Apr-4 | 64.83 | 65.05 | 67.25 | 64.67 |
| Apr-5 | 64.40 | 62.90 | 64.45 | 62.33 |
| Apr-8 | 63.21 | 64.09 | 64.22 | 62.51 |
| Apr-9 | 64.00 | 65.23 | 65.24 | 63.07 |
| Apr-10 | 62.10 | 61.72 | 62.93 | 60.31 |
| Apr-11 | 62.69 | 62.95 | 63.08 | 61.32 |
| Apr-12 | 62.23 | 60.67 | 62.35 | 60.25 |
| Apr-15 | 60.74 | 58.72 | 60.95 | 58.47 |
| Apr-16 | 58.04 | 57.97 | 58.74 | 57.14 |
| Apr-17 | 58.34 | 55.56 | 58.47 | 55.52 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.57 per share, a decrease next quarter of $0.20 per share, a decrease this year of $2.71 per share, and an increase next year of $1.61 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.